OA08890A - Double-stranded RNA correction of abnormalitie in circulating immune complexes and monocyte function. - Google Patents

Double-stranded RNA correction of abnormalitie in circulating immune complexes and monocyte function.

Info

Publication number
OA08890A
OA08890A OA59387A OA59387A OA08890A OA 08890 A OA08890 A OA 08890A OA 59387 A OA59387 A OA 59387A OA 59387 A OA59387 A OA 59387A OA 08890 A OA08890 A OA 08890A
Authority
OA
OAPI
Prior art keywords
double
stranded rna
immune complexes
abnormalitie
circulating immune
Prior art date
Application number
OA59387A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08890A publication Critical patent/OA08890A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
OA59387A 1987-07-17 1988-07-15 Double-stranded RNA correction of abnormalitie in circulating immune complexes and monocyte function. OA08890A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7461687A 1987-07-17 1987-07-17
US12457787A 1987-11-24 1987-11-24

Publications (1)

Publication Number Publication Date
OA08890A true OA08890A (en) 1989-10-31

Family

ID=26755855

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59387A OA08890A (en) 1987-07-17 1988-07-15 Double-stranded RNA correction of abnormalitie in circulating immune complexes and monocyte function.

Country Status (18)

Country Link
EP (1) EP0300680B1 (fr)
JP (1) JP2601520B2 (fr)
KR (1) KR0131880B1 (fr)
CN (1) CN1035050A (fr)
AT (1) ATE142500T1 (fr)
AU (2) AU1820588A (fr)
CA (1) CA1326999C (fr)
DE (1) DE3855527T2 (fr)
DK (1) DK399288A (fr)
ES (1) ES2093607T3 (fr)
FI (1) FI883352A7 (fr)
HU (1) HUT47432A (fr)
IE (1) IE76914B1 (fr)
IL (1) IL86862A (fr)
NO (1) NO175023C (fr)
NZ (1) NZ225310A (fr)
OA (1) OA08890A (fr)
PT (1) PT87996B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
WO1991005560A1 (fr) * 1989-10-11 1991-05-02 Hem Research, Inc. Protection contre un choc posterieur a une blessure a l'aide d'arn bicatenaires
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
WO1993001717A1 (fr) * 1991-07-16 1993-02-04 Hem Pharmaceuticals Corp. Modulation et diagnostic du dysfonctionnement des cytokines
TW589189B (en) * 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO1999049029A1 (fr) 1998-03-20 1999-09-30 Benitec Australia Ltd Controle d'expression genique
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (fr) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (fr) 2001-01-31 2002-07-31 Nucleonics Inc. Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule
WO2006071934A2 (fr) * 2004-12-29 2006-07-06 Mannkind Corporation Procedes permettant de declencher, maintenir et manipuler des modificateurs de reponse biologique a l'interieur d'organes lympoides
GB2555364A (en) * 2015-11-17 2018-04-25 Grund IP Group Novel pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and polyalkyleneimine
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4140761A (en) * 1977-04-11 1979-02-20 The United States Of America As Represented By The Department Of Health, Education & Welfare Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
NZ225310A (en) 1991-05-28
FI883352L (fi) 1989-01-18
JP2601520B2 (ja) 1997-04-16
NO882853D0 (no) 1988-06-28
IE881894L (en) 1989-01-17
ATE142500T1 (de) 1996-09-15
JPS6490126A (en) 1989-04-06
IL86862A (en) 1993-05-13
KR890001580A (ko) 1989-03-27
FI883352A0 (fi) 1988-07-14
ES2093607T3 (es) 1997-01-01
CN1035050A (zh) 1989-08-30
PT87996B (pt) 1995-03-31
DE3855527D1 (de) 1996-10-17
CA1326999C (fr) 1994-02-15
EP0300680B1 (fr) 1996-09-11
EP0300680A3 (fr) 1991-06-19
PT87996A (pt) 1989-06-30
AU1820588A (en) 1989-01-19
HUT47432A (en) 1989-03-28
DK399288A (da) 1989-01-18
KR0131880B1 (ko) 1998-04-17
DK399288D0 (da) 1988-07-15
NO175023B (no) 1994-05-09
NO175023C (no) 1994-08-17
NO882853L (no) 1989-01-18
FI883352A7 (fi) 1989-01-18
IE76914B1 (en) 1997-11-05
DE3855527T2 (de) 1997-04-03
IL86862A0 (en) 1988-11-30
EP0300680A2 (fr) 1989-01-25
AU1761195A (en) 1995-06-29

Similar Documents

Publication Publication Date Title
OA08890A (en) Double-stranded RNA correction of abnormalitie in circulating immune complexes and monocyte function.
PT707487E (pt) Metodos e composicoes farmaceuticas uteis no tratamento de disturbios neurologicos
SI0691130T1 (en) Use of rapamycin in the manufacture of a medicament for preventing and heating hyperproliferactive vascular diseases, eventually in combination with mycophenolic acid
DE3764253D1 (de) Medizinischer saugkoerper mit roentgenkontrastmittel und verfahren zu seiner herstellung.
EP0378692A4 (en) Catheter for medical treatment
EP0306347A3 (en) Diagnosis and treatment of double-stranded rna deficiency states
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
Hassenfeld et al. A study of the right to refuse treatment.
ZA857721B (en) Process for treatment of rheumatic diseases
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
EP0292397A3 (en) Extracorporeal blood circulating apparatus
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
Phillips Therapy with cancer patients: a phenomenological study
EP0292398A3 (en) Extracorporeal blood circulating apparatus
EP0292396A3 (en) Extracorporeal blood circulating apparatus
TW217382B (fr)
RU94001222A (ru) Способ лечения воспаленных тканей организма
UA10335A (uk) Спосіб корекції порушеhь обміhу кальцію у хворих hа сиhдром рейтера хламідійhої етіології